Henry Mankin

Author PubWeight™ 40.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Langerhans cell histiocytosis. Skeletal Radiol 2006 1.62
2 MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther 2011 1.51
3 Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys 2006 1.50
4 Osteoblastoma: a 30-year study of 99 cases. J Surg Oncol 2008 1.40
5 Osteoid osteoma and osteoblastoma. J Am Acad Orthop Surg 2011 1.23
6 CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. Cancer Chemother Pharmacol 2008 1.23
7 Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression. J Orthop Res 2010 1.16
8 Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. PLoS One 2010 1.16
9 A novel target for treatment of chordoma: signal transducers and activators of transcription 3. Mol Cancer Ther 2009 1.07
10 Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer. Clin Cancer Res 2010 1.06
11 Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma. BMC Cancer 2009 1.05
12 ROCK1 as a potential therapeutic target in osteosarcoma. J Orthop Res 2011 1.04
13 Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines. Mol Cancer Ther 2009 1.04
14 Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis. J Orthop Res 2010 1.03
15 Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells. Cancer Chemother Pharmacol 2010 1.01
16 A validated disease severity scoring system for adults with type 1 Gaucher disease. Genet Med 2010 1.01
17 The kinase Mirk is a potential therapeutic target in osteosarcoma. Carcinogenesis 2009 1.01
18 Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferation. Clin Cancer Res 2012 0.99
19 Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma. Anticancer Res 2009 0.97
20 Characterization and analysis of human chordoma cell lines. Spine (Phila Pa 1976) 2010 0.97
21 Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma. Cancer Lett 2010 0.97
22 Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy. Blood Cells Mol Dis 2002 0.96
23 Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma. PLoS One 2013 0.95
24 Targeting hedgehog-GLI-2 pathway in osteosarcoma. J Orthop Res 2012 0.92
25 Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells. Cancer Lett 2013 0.89
26 Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer. Mol Cancer Ther 2008 0.89
27 Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell lines. Anticancer Res 2011 0.88
28 Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo. Anticancer Drugs 2011 0.87
29 Synthesis and evaluation of (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) isomers to reverse multidrug resistance in cancer. J Med Chem 2012 0.87
30 Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor trafficking. Mol Cancer Ther 2010 0.87
31 Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma. J Orthop Res 2014 0.86
32 Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expression. Apoptosis 2009 0.85
33 ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell lines. PLoS One 2009 0.83
34 Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014. Am J Hematol 2014 0.82
35 Blockage of Stat3 with CDDO-Me inhibits tumor cell growth in chordoma. Spine (Phila Pa 1976) 2010 0.82
36 RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines. Cancer Chemother Pharmacol 2009 0.82
37 Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay. J Biomol Screen 2010 0.82
38 Prevalence of type 1 Gaucher disease in the United States. Arch Intern Med 2008 0.81
39 Use of plain radiography to optimize skeletal outcomes in children with type 1 Gaucher disease in Brazil. J Pediatr Orthop 2007 0.80
40 A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells. BMC Cancer 2014 0.78
41 Sarcoidosis of the spine: a report of five cases and a review of the literature. J Bone Joint Surg Am 2012 0.76
42 Development of a new pre-vascularized tissue-engineered construct using pre-differentiated rADSCs, arteriovenous vascular bundle and porous nano-hydroxyapatide-polyamide 66 scaffold. BMC Musculoskelet Disord 2013 0.75